Filing Details

Accession Number:
0001209191-19-009430
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-12 17:33:11
Reporting Period:
2019-02-12
Accepted Time:
2019-02-12 17:33:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS Pharmaceutical Preparations (2834) 475461709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740847 Bryan Giraudo 3013 Science Park Road
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-12 17,879 $0.00 17,879 No 4 C Direct
Common Stock Acquisiton 2019-02-12 6,000 $16.00 23,879 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-02-12 57,142 $0.00 12,698 $0.00
Common Stock Series B Preferred Stock Disposition 2019-02-12 23,316 $0.00 5,181 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.